Background: Participatory approaches involving stakeholders across the health care system can help enhance the development, implementation and evaluation of health services. These approaches may be particularly useful in planning community pharmacy services and so overcome challenges in their implementation into practice. Conducting a stakeholder analysis is a key first step since it allows relevant stakeholders to be identified, as well as providing planners a better understanding of the complexity of the health care system. Objectives: The main aim of this study was to conduct a stakeholder analysis to identify those individuals and organizations that could be part of a leading planning group for the development of a community pharmacy service (CPS) to prevent cardiovascular disease (CVD) in Australia. Methods: An experienced facilitator conducted a workshop with 8 key informants of the Australian health care system. Two structured activities were undertaken. The first explored current needs and gaps in cardiovascular care and the role of community pharmacists. The second was a stakeholder analysis, using both ex-ante and ad-hoc approaches. Identified stakeholders were then classified into three groups according to their relative influence on the development of the pharmacy service. The information gathered was analyzed using qualitative content analysis. Results: The key informants identified 46 stakeholders, including (1) patient/consumers and their representative organizations, (2) health care providers and their professional organizations and (3) institutions and organizations that do not directly interact with patients but organize and manage the health care system, develop and implement health policies, pay for health care, influence funding for health
Introduction
Current approaches to health planning underline the importance of involving stakeholders across the health care system early in the planning process, in order to overcome challenges in the implementation of health services into practice. [1] [2] [3] According to Varvasovskzky and Brugha, 4 stakeholders are "actors who have an interest in the issue under consideration, who are affected by the issue, or who -because of their positionhave or could have an active or passive influence on the decision-making and implementation processes." Theory 5 and experience 6, 7 suggest that multilevel stakeholder groups bring different benefits to health service planning processes, such as in-depth knowledge of the context in which the service will be implemented, innovative ideas, and logistic and financial support. Moreover, the collaboration between stakeholders makes health service planning more transparent, nurtures networking, increases the translation of research findings into practice, fosters co-learning, and develops stakeholders' feelings of ownership on the planned health services. [8] [9] [10] [11] [12] [13] As a result of participatory planning approaches, health services and associated reforms of the health care system are not only more likely to address the existing or emerging population and system needs, but also to be suitably and efficiently developed, implemented and evaluated. 2, 5, 10, 14 According to the guidelines for the design of participatory processes, 15 these processes must be informed by a stakeholder analysis (also called stakeholder mapping). A stakeholder analysis encompasses identifying and assessing the individuals and organizations that have a vested interest or can influence a particular initiative. Thus, stakeholder mapping can be used to generate knowledge about the relevant actors related to a particular issue allowing for a deeper understanding of their relative influence and interest on a problem. Importantly it can also provide useful information on the likely role that they may or can play in solving the problem. As a result, the stakeholders that are critical and crucial for the success of a particular initiative can be clearly determined, and solutions that are feasible and acceptable from multiple perspectives can be found. 10, 16 Due to their usefulness, stakeholder analysis are applied in a variety of sectors (e.g., business management, 17 public and non-forprofit management, 12 health management, 16 health policy, 16 biosecurity risk, 14, 18 natural resource management research 19 ). Reed and Curzon 10 described three different theoretical approaches to stakeholder mapping (i.e., normative, instrumental and descriptive) along with the methods that can be used for identifying and categorizing stakeholders, and analyzing their relationships. Bryson 12 described a range of stakeholder identification and analysis techniques classified into 4 broad categories according to their purpose: (1) organizing participation; (2) creating ideas for strategic interventions; (3) building a winning coalition around proposal development, review and adoption; and (4) implementing, monitoring and evaluating strategic interventions. Despite their wide use, stakeholder analyses are often undertaken without following a systematic process. 19 Different methods for data gathering have been described in the literature, including interviews with individuals; structured questionnaires; workshops and focus groups with multiple participants; expert opinions; snowballing sampling; etc. 16, 19 It should be noted that the theoretical approaches, methods and techniques to be used in a particular stakeholder analysis should be selected and adjusted according to the particular purpose of the analysis, the timing in which it is conducted (i.e., stage of the project) as well as the availability of resources. 16 In order to facilitate the understanding of the complexity of the results of stakeholder analyses, various graphical techniques can be used, including stakeholder maps and matrices. For example, Herna´n-dez-Jover et al 18 used a stakeholder identification map for the representation of stakeholders and several matrices in which stakeholders were located according to their influence and interest on 3 core issues.
In the context of health service planning, conducting a stakeholder analysis at the onset of the planning process not only clarifies the complexity of the context in which services will be implemented but also avoids the involvement of stakeholders who are not representative. 9, 10 In this regard, a recent analysis on current service development practices highlights the role of stakeholder maps in explicitly conducting an early exploration of the 'ill-defined problem space' before generating a particular solution. 20 Despite its importance, stakeholder mapping is poorly described in the health service literature, where, interestingly, a number of articles reporting the development of health programs that used participatory planning approaches lack this type of analysis. 6, [21] [22] [23] Without such information, it is difficult to understand the reasons behind the involvement of each stakeholder or to be certain that the key stakeholders have been engaged. An appropriate description of stakeholder analysis 24, 25 meets the recommendations for comprehensively reporting participatory processes 6 and increases the transparency of such processes, allowing for their evaluation and improvement.
Participatory planning approaches are useful in pharmacy practice, where the development, evaluation and implementation of services, and the integration of community pharmacists into the health care team still remains a challenge. 26, 27 The planning process and development of CPSs is further discussed elsewhere along with some general information about how research can inform such a process. 27 A stakeholder analysis is a type of study that should be conducted at the outset of the CPS planning process to inform the group of stakeholders that may be involved in such a process. A multilevel stakeholder group may help understand and address the complexities of the health care system in which community pharmacy services (CPSs) need to be embedded, and so improve the implementation of those services. 27, 28 A specific area in which CPSs are seen to be particularly relevant is in the prevention of cardiovascular disease (CVD), 29 which is a major public health problem. 30, 31 According to the World Health Organization, interventions at the primary-care level are considered to be the optimal approach to reverse the progression of CVD, prevent long-term complications, and reduce the use of associated health care resources. 31 Community pharmacists are highly accessible health care professionals at the primary-care level and their positive impact on the control of cardiovascular risk factors has already been shown. 29 In order to promote the development and further implementation of a CPS aimed at preventing CVD in Australia, this study conducted a stakeholder analysis to identify those key stakeholders that could be part of a leading planning group. As a secondary objective, current gaps and needs in cardiovascular care and the role of community pharmacists were explored.
Material and methods

Study design
A workshop was carried out at the University of Technology, Sydney (UTS), with a group of 8 key informants. A 'descriptive' theoretical approach, which aims to understand the relationships between a particular issue and its stakeholders, 19 was adopted in the stakeholder analysis. The design of the study was based on the approaches proposed by Varvasovszky and Brugha 4 and Reed et al. 19 To stimulate discussions Varvasovszky and Brugha's 4 suggestions of face-to-face discussions between a broad group of informants (i.e. insiders and outsiders to the project) with different backgrounds, expertise and roles within the health care system were used. This provided a comprehensive view of the Australian health care system, neutralized individual biases and questioned individually held assumptions. All participants were potential stakeholders to the project, which allowed for enhancing the quality and credibility of both the analysis and the results as suggested by Reed et al. 19 Key informants were purposively selected because they had complementary profiles and were potential stakeholders in the project. Key informants' profiles encompassed community pharmacy managers/owners with experience in service provision and connected to pharmacy professional organizations; an experienced cardiologist; a nurse/cardiovascular researcher related to different cardiovascular and nurse associations; a hospital pharmacist and executive at a governmental advisory organization promoting quality use of medicines; an executive of a cardiovascular network with experience in the pharmacy industry; and academics/researchers with wide experience in pharmacy practice/service research.
Workshop organization
The general structure of the workshop can be seen in Fig. 1 and included two main activities:
Activity 1: Exploring the needs and gaps in cardiovascular care and the roles of community pharmacists. This preliminary discussion was used to prompt key informants to share ideas and feel comfortable in order to establish a common ground for the next activity regarding the identification of stakeholders. To facilitate the identification of gaps in cardiovascular care, participants were given a handout (Appendix 1) containing a list of cardiovascular risk factors and diseases (based on WHO Global Atlas on cardiovascular disease prevention and control 31 ). The handout also contained a list of potential roles of community pharmacists in cardiovascular care (informed from the literature 29 ) , with the intention of stimulating discussion between key informants and prompting some ideas.
Activity 2: Stakeholder identification and classification. The key informants were asked to identify stakeholders with a vested interest in the development of a CPS aimed at preventing CVD. To drive the exercise, the following definition of stakeholder was provided: "any individual or organization that can be directly or indirectly affected by, have an influence on, or have an interest in the development of a CPS aimed at the prevention of cardiovascular diseases" (adapted from Varvasovskzky and Brugha 4 ). The identification of stakeholders was made using both ex-ante and ad-hoc approaches. These approaches are complementary and the combination of both enables more information to be collected. 10 The ex-ante approach recommends identification of stakeholders in advance. Relevant stakeholders were identified by researchers from the literature prior to the workshop. These identified stakeholders, grouped in categories as adapted from Preskill and Jones, 5 were used in the workshop as examples in a handout provided to key informants (Table 1 ). In contrast, the ad-hoc approach does not provide probable stakeholders a priori but encourages stakeholder identification by key informants using questions. For this purpose, questions adapted from Gilmour and Beilin, 14 were projected onto a slide ( Table 1 ). The identified stakeholders were then classified into three groups according to the relative influence that they were considered to have on the development of the CPS (adapted from Covey's circle of concern/circle of influence 32 ):
1. Control: stakeholders who have the ability to control the development of the service, can prevent it from progressing or help make it happen. 2. Influence: stakeholders who have the ability to influence the development of the service -i.e. have less control but are still important to making it happen. 3. Interest/concern: stakeholders who may be interested in or concerned with the service but will not significantly influence whether or not the project goes ahead.
Following current recommendations for designing public participation processes, 15 discussions between key informants regarding the classification of stakeholders were held until consensus was reached to ensure that the key stakeholders that need to be involved in the first phase of the CPS planning process were identified.
In order to enhance the future feasibility of the project, some geographical boundaries were set (i.e., questions to the key informants were focused on New South Wales, Australia). This decision was made based on existing frameworks for health service/program planning. 1, 27, 33 These frameworks suggest services/programs should be developed and piloted (for optimization) in limited geographical areas before further impact and outcome evaluation and scaling-up. An external, experienced facilitator conducted the workshop. The facilitator was experienced in systems thinking, community engagement and stakeholder mapping. While she did not have experience with health care in particular, she did have extensive experience in designing and facilitating workshops with stakeholders across diverse disciplinary fields and industry sectors including the energy, mining and education sectors. The facilitator ensured that goals of the meeting were met within the designated timeframe; the group did not diverge from the set agenda; both dominant and withdrawn participants were managed to ensure all voices were heard; the composition of groups when participants were separated for discussion was balanced; and findings were validated through group feedback processes at the end of the workshop. Two researchers took notes and the workshop was audiotaped and transcribed. Butchers paper and Post-it notes were used during the activities and collected at the end of the workshop. The UTS Human Research Ethics Committee approved the study ( 
Data analysis
The information sources (i.e. transcripts, researchers' notes, Post-it notes and butchers paper) were analyzed using qualitative content analysis, which allowed categories to emerge from the data and acknowledged the significance of the context in which the analyzed information was generated. 34, 35 Qualitative content analysis has been found to be a useful analytical technique in health research. [36] [37] [38] This type of analysis is appropriate to describe the meaning of the answers of a wide variety of questions in a systematic way. It focusses on extracting categories from the data and is a flexible technique that can be used with both inductive and deductive approaches. 35, 39 A deductive approach using a 4-step coding process was followed. First, one reviewer read through the information sources several times and created a preliminary list of prior categories. Second, the text was coded according to these categories; when relevant information could not be coded into an existing category, a new category was created. Third, categories were reviewed to either create sub-categories or merge categories that addressed similar issues. The results derived from this process were discussed with a second researcher in order to improve the interpretation of the information and the credibility of the results. The trustworthiness of the qualitative content analysis was assured by addressing credibility, dependability and transferability of the data. 40 Credibility was reinforced by choosing participants with various perspectives and experiences, selecting how to gather data and verifying that categories covered the whole data during the analysis. Dependability was assured by bringing participants together in a workshop and collecting data at a specific point of time to avoid the risk of inconsistency in the data due to the phenomena of interest changing over time. Finally, regarding transferability of key themes, a detailed description of the characteristics of participants, methodology, and findings was presented in order to help readers elucidate the extent to what the findings can be transferred to a different context. Microsoft Excel 2010. Ink was used to manage and analyze the data.
Results and discussion
Although the activities of the workshop were planned in a specific order, the results section is Who may be affected by this?
Who might influence the change?
Who has the power to make/stop it happening?
Where might funding/financing come from?
Who are potential allies or opponents?
What coalitions might build around this issue?
organized to first address the primary objective of the study.
Identifying and mapping stakeholders
Key informants identified 46 stakeholders across the health care system. A detailed stakeholder map is shown in Fig. 2 To the best of our knowledge, this is the first stakeholder analysis that uses a systematic approach with potential stakeholders to inform the development of a CPS. Recently, Vozikis et al 28 used a stakeholder analysis to research the complexity of the system in which community pharmacists are embedded focusing on health policy, while the objective of the stakeholder analysis in this study was health service development. According to results of the stakeholder identification process, it can be argued that CPS planning must involve a wide range of stakeholders with complementary roles within the health care system to facilitate the development and implementation of those services and so the integration of community pharmacists into the primary health care team. In fact, according to key informants, not considering the complexity of the health care system in which CPSs will be implemented and the wide array of stakeholders (and their personal interests and power) may partly explain why previous experiences aiming at implementing these services have failed (quotes 1 and 2, Table 2 ). As argued by several authors, [41] [42] [43] the early engagement and input of a diversity of stakeholders in the planning process is crucial to successfully implement highly valuable health services. In fact, current co-design approaches involve service participants (e.g. patients, carers, health service providers) in early planning stages to enhance existing health services, 44 develop new ones, 45 or adapt evidencebased interventions from other contexts. 46 Beyond the contribution of service participants, high-level stakeholders (e.g. policy makers, managers, payers) bring important insights to the process not only by sharing their broad knowledge about the health care system (e.g. organization, regulation, resources) but also by providing logistic and financial support. 6 The relevance and usefulness of participatory approaches has begun to be reported in CPS planning in Canada and New Zealand. 6, 47 When the key informants estimated the relative influence of each stakeholder on the development of a CPS, 19 were considered to have "control" over the situation, 16 to have "influence" and 11 to have an "interest/concern" (Fig. 2) . Among the 19 included in the "control group," key informants agreed on a "core group of 12 stakeholders" (Fig. 2 ) that were considered crucial for ensuring the service's development, because they held positions that could drive (or inhibit) the project's progress (quotes 3 to 6, Table 2 ). The key informants also commented that if this core group of stakeholders could work together, other stakeholders would join the process (quote 3, Table 2 ). Specifically, the 12 stakeholders that were considered the core group were: Primary Healthcare Networks, Agency for Clinical Innovation, Chronic Cardiovascular Clinical Expert Reference Group, Office for Health and Medical Research, Local Health Districts & Specialty Networks, Heart Foundation, Pharmacy Guild of Australia, Australian Medical Association, The Royal Australian College of General Practitioners, individual patients, patient groups/organizations (including diseaseoriented), and Consumer Health Forum of Australia. The configuration of this group encompasses different key profiles, such as endbeneficiaries of the service and health care professionals, leading cardiovascular organizations, health-system managers, and health policy makers and regulators, who can be also payers.
Interestingly, these stakeholder profiles have been shown to be the main promoters of service development projects in mental health. 20 As recommended by the guidelines for designing public participation processes, 15 by reaching this agreement, this stakeholder analysis ensured that the key stakeholders that should be involved at this stage of the process were identified. From a planning perspective, the identification of a core group of stakeholders has allowed for the prioritization of stakeholders that will be initially approached in future workshops aimed at developing a vision (i.e. visioning exercise 48 ) on how to further integrate CPS to enhance cardiovascular care. According to the key informants, the relative importance of the identified stakeholders may change depending on the stage of a patient's journey (i.e. settings, care processes) that the service will be focused on (quote 7, Table 2 ). This observation is consistent with existing stakeholder theory, 10, 17, 49 which states that the influence, interest or involvement of stakeholders in a project may vary depending on several circumstances. For example, planning a CPS addressing the needs of patients being discharged from • Consumer Health Forum of Australia (Co)* (potentially, also other national/state consumer groups/organisations)
• Heart Support Australia (I/C) (potentially, also other patient support groups/organisations, including home service providers)
• Patients carers, family members and friends †
• Individual pharmacists (Co)
• Pharmacy Guild of Australia (Co)*
• Pharmaceutical Society of Australia (In)
• The Society of Hospital Pharmacists of Australia (In)
• Australian Association of Consultant Pharmacy (I/C)
• Individual doctors (e.g., general practitioners, specialists, etc.) (Co)
• Australian Medical Association (Co)*
• The Royal Australian College of General Practitioners (Co)*
• Cardiac Society of Australia & New Zealand (CSANZ) (In)
• Hospital Cardiology Units (Co)
• Australian Primary Health Care Nurses Association (I/C)
• Cardiovascular Nurses Council -CSANZ (I/C)
• Australian Cardiovascular Health and Rehabilitation Association (I/C)
• Aboriginal Medical Services (Co)
• Aged care facilities (In)
• Psychologists / behavioural change experts(I/C)
Pharmacy-based stakeholders Doctors Allied healthcare professionals
• Heart Foundation (Co)*, including clinical committees (Co) and volunteers (I/C)
• NSW Cardiovascular Research Network (In)
• Diabetes Australia (In)
• Heart Kids NSW (In)
• Kidney Health Australia (In)
• Stroke Foundation NSW (In)
• • Healthcare setting (e.g., hospital) administrators, managers or executives (Co)
• Health Insurance Companies (In)
• Pharmacy Industry (In)
• Medicines Australia (In)
• UTS (Co), including UTS experts in health service planning and cardiovascular (In) (potentially, also other universities and experts)
• Health technology providers/enablers (e.g. Fitbit, GuildLink software) (In)
• NPS Medicine Wise (In)
• Pharmacy banner groups (I/C) and Franchise pharmacy models (I/C)
• 6th Community Pharmacy Agreement funding board (I/C)
Other high-level stakeholders Fig. 2 . Stakeholder map z . CVD: cardiovascular disease; NSW: New South Wales (Australia); UTS: University of Technology, Sydney; Co: control (i.e., the stakeholder is considered to have the ability to control the development of the service, can prevent it from progressing or help make it happen); In: influence (i.e., the stakeholder is considered to have the ability to influence the development of the service; they have less control but are still important to making it happen); I/ C: interest/concern (i.e., stakeholders who may be interested in or concerned with the service but will not significantly impact on whether or not the project goes ahead). z This figure was created based on the whole information collected as part of the workshop including transcripts, butchers paper, post-it notes and researchers' notes. y These stakeholders were included by the researchers based on existing theory. * Stakeholders considered core by the key informants.
hospital might not consider the same stakeholders as a service addressing the promotion of healthy lifestyle habits in healthy people. Aside from this example, two other situations were highlighted in this mapping exercise. First, at this stage of the planning process, the health problem was still too broad (i.e. encompassing a wide spectrum of conditions, risk factors and different levels of prevention), which resulted in a similarly broad group of stakeholders being identified. In future, the definition of a specific issue and target population within the cardiovascular spectrum will narrow the group of stakeholders. When the boundaries of the service have been clearly established, it will be advisable to explore in depth the role, the interests, and existing relationships between, the stakeholders. 10, 12, 14, 19 Second, this stakeholder analysis focused on the development of the service, mainly encompassing the theoretical design of the service and piloting for optimization. 27 According to health planning approaches, the relative interest, influence or involvement of different stakeholders throughout the stages of the planning process (i.e. development, implementation, evaluation) may change depending on the aims of each stage. 2, 3 That is to say, the configuration of planning groups should be regularly examined to both ensure that the right stakeholders are involved at each stage of the planning process, and enable new members to join the group and so bring new ideas and enthusiasm to the discussion. 33 As a result, stakeholder analysis should be an ongoing exercise that needs to be conducted several times throughout the service planning process. 10, 14 This will allow suitable changes in the composition of planning groups to align with the needs of the planning process.
Although a first comprehensive stakeholder analysis should be conducted at the outset of any CPS planning process, occasionally resource-, time-or funding constraints can limit the breadth and depth of this analysis. 4 If logistics do not allow for direct interaction with stakeholders to conduct a stakeholder mapping, planners still need to approach the identification of stakeholders. Different methods can be used including: analyzing documents and literature relevant to the phenomenon of interest, information published in the websites of the organizations that are related to the topic, gathering expert opinions, or using questionnaires. 4, 19 The results of this study can help pharmacy service planners identify and select relevant stakeholders. This is because the present stakeholder analysis can frame and provide insight into the individual profiles, roles, settings, system organizations etc. that can be involved in other CPS planning processes. Finally, in order to design and conduct this study, the project team engaged cross-disciplinary input, collaborating with social scientists with expertise in qualitative methods, stakeholder mapping and facilitation skills. As far as we are aware, training in stakeholder mapping techniques is not typically available for pharmacy researchers. We suggest that more attention should be given to this training when the education of researchers in service development is outlined, since the stakeholder analysis is a very first step of the planning process of a service and informs the group of stakeholders that should lead and manage such a process.
Needs or gaps in cardiovascular care and potential roles of community pharmacies
With regard to the secondary objective of this study, key informants disclosed several gaps or needs in current cardiovascular care practice and associated roles of community pharmacists in the prevention and management of CVD (Table 3) . This information rounds out the stakeholder identification process, providing preliminary insight about the problem to be addressed and how community pharmacists can be involved in such a problem. 19 In the future, these secondary results can be used to inform early planning steps and discussions aimed at defining a specific problem situation to be targeted by the CPS. It should be noted that the roles of community pharmacists identified by the key informants in this study have already been reported (and claimed) in previous studies conducted in Australia, 50, 51 which emphasizes the existing need to develop and implement cardiovascular CPSs into primarycare practice.
As part of the same discussion, key informants addressed several factors that can hinder the integration of CPSs into practice (i.e., barriers) ( Table 4) . Although the list of factors in Table 4 is not comprehensive, it is consistent with the findings of previous studies that assessed the barriers to the expansion of the community pharmacist's role in Australia 51 or the use of community pharmacy public health services in England. 52 Key informants put special emphasis on the poor coordination between health care processes and services within the health care system and the poor communication and collaboration between health care professionals (e.g. community pharmacists and general practitioners). Once again, the identified barriers highlight the importance of involving multilevel stakeholder groups in planning CPSs. This is because most of the barriers may require strategies and interventions Educating patients to optimize medication use and knowledge Conducting medication reviews (e.g., discharge medication reviews and home medication reviews), checking drug interactions and toxicities Monitoring and promoting medication adherence (especially when diseases are asymptomatic) Performing dose administration aids Enhance early diagnose and treatment of cardiovascular risk factors
Screening high risk patients and refer them to the GPs for diagnosis when needed (Related quote in appendix 3: 31) targeting different organizations, settings, processes and individuals across the health care system to be suitably addressed. 53, 54 Limitations. The information gathered in this study represents a 'snapshot' of a system that is continuously changing (i.e., the obtained information is provisional). There is a recommendation of repeating the stakeholder analysis throughout the planning process in order to update results and so ensure that the right stakeholders are involved and that new members are enabled to join the group. 10, 14 A deeper understanding of the roles and relationships of the stakeholders was not considered as this change as the planning process proceeds to more definite service definition. It should be noted that patient carers, family members and friends were not specifically named in this mapping exercise. Different authors consider this "interpersonal support network" of patients essential stakeholders in participatory research approaches 8 and the co-design of health services. [55] [56] [57] [58] "Carers or loved ones" are also an intrinsic part of the definition of "patient" provided by the King's Fund toolkit for experiencebased co-design. 56 For these reasons, they have been added as part of the list of stakeholders in this exercise.
Conclusions
This stakeholder analysis provided a detailed picture of the wide range of individuals and organizations that have a stake in the development of a CPS aimed at preventing CVD. Stakeholders were distributed across the whole health care system and were considered to have different influences in the development of the service. These results underline the need for multilevel stakeholder groups to deal with the complexity of the health care system in which CPSs are to be embedded and so facilitate the integration of community pharmacists into the primary health care team. A core group of stakeholders with complementary roles was also defined. This group can ensure the development of the service and strongly influence progress. Stakeholders in the core group will be approached to collaboratively plan the proposed community pharmacy service. Finally, useful information concerning the gaps and needs in current cardiovascular care, the role of community pharmacists in cardiovascular prevention and the factors that can affect the implementation of a community pharmacy service, was obtained.
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